Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.77 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | ALPG | P10696 | 1/20 | 0.50 |
| ▸ | KLK7 | P49862 | 3/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9803692 | 0.94 | TDP1 (0.73) | L3MBTL1TDP1PTPN1LMNACES2 | |
| SCHEMBL16781993 | 0.90 | L3MBTL1 (0.61) | L3MBTL1TDP1PTPN1LMNACES2 | |
| SCHEMBL16807289 | 0.90 | TDP1 (0.61) | L3MBTL1TDP1PTPN1LMNACES2 | |
| SCHEMBL16781988 | 0.88 | TDP1 (0.59) | L3MBTL1TDP1PTPN1LMNACES2 | |
| SCHEMBL6708325 | 0.88 | L3MBTL1 (0.59) | L3MBTL1TDP1PTPN1LMNASMN1; SMN2 | |
| SCHEMBL2927912 | 0.88 | L3MBTL1 (1.00) | L3MBTL1TDP1PTPN1LMNACES2 | |
| SCHEMBL16781998 | 0.84 | L3MBTL1 (0.69) | L3MBTL1TDP1PTPN1LMNACES2 | |
| SCHEMBL17583713 | 0.82 | L3MBTL1 (0.80) | L3MBTL1TDP1PTPN1LMNACES2 | |
| SCHEMBL16807278 | 0.82 | L3MBTL1 (0.80) | L3MBTL1TDP1PTPN1LMNACES2 | |
| SCHEMBL17583575 | 0.82 | L3MBTL1 (0.80) | L3MBTL1TDP1PTPN1LMNACES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9656947-B2 | Process for creating carbon-carbon bonds using carbonyl compounds | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) | 2017-05-23 | — | — | US | disclosed |
| US-9656947-B2 | Process for creating carbon-carbon bonds using carbonyl compounds | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) | 2017-05-23 | — | — | US | disclosed |
| EP-2858966-B1 | PROCESS FOR CREATING CARBON-CARBON BONDS USING CARBONYL COMPOUNDS | CENTRE NAT RECH SCIENT (FR) | 2016-08-10 | — | — | EP | disclosed |
| US-20150166464-A1 | PROCESS FOR CREATING CARBON-CARBON BONDS USING CARBONYL COMPOUNDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N. R.S.) (FR) | 2015-06-18 | — | — | US | disclosed |
| US-20150166464-A1 | PROCESS FOR CREATING CARBON-CARBON BONDS USING CARBONYL COMPOUNDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N. R.S.) (FR) | 2015-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166464-A1 | PROCESS FOR CREATING CARBON-CARBON BONDS USING CARBONYL COMPOUNDS | CBR3, CBR1, CYP4F3 | L3MBTL1 4386/4885TDP1 4876/4885PTPN1 4167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.